Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis-Reference-Cited by-同舟云学术

Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis

Published:2017-04-10 Issue:5 Volume:23 Page:590-600
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Romani Luigina^ORCID,Oikonomou Vasilis,Moretti Silvia,Iannitti Rossana G,D'Adamo Maria Cristina,Villella Valeria R,Pariano Marilena,Sforna Luigi,Borghi Monica,Bellet Marina M^ORCID,Fallarino Francesca,Pallotta Maria Teresa,Servillo Giuseppe,Ferrari Eleonora,Puccetti Paolo,Kroemer Guido,Pessia Mauro,Maiuri Luigi,Goldstein Allan L,Garaci Enrico

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.4305.pdf

Reference69 articles.

1. Rowe, S.M., Miller, S. & Sorscher, E.J. Cystic fibrosis. N. Engl. J. Med. 352, 1992–2001 (2005).

2. Lukacs, G.L. & Verkman, A.S. CFTR: folding, misfolding and correcting the ΔF508 conformational defect. Trends Mol. Med. 18, 81–91 (2012).

3. Okiyoneda, T. et al. Peripheral protein quality control removes unfolded CFTR from the plasma membrane. Science 329, 805–810 (2010).

4. Pedemonte, N. et al. Small-molecule correctors of defective ΔF508-CFTR cellular processing identified by high-throughput screening. J. Clin. Invest. 115, 2564–2571 (2005).

5. Galietta, L.J. Managing the underlying cause of cystic fibrosis: a future role for potentiators and correctors. Paediatr. Drugs 15, 393–402 (2013).

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic drug discovery: a case for thymosin alpha-1;Frontiers in Medicine;2024-06-06

2. Mechanism and clinical application of thymosin in the treatment of lung cancer;Frontiers in Immunology;2023-08-28

3. Innovative Strategy toward Mutant CFTR Rescue in Cystic Fibrosis: Design and Synthesis of Thiadiazole Inhibitors of the E3 Ligase RNF5;Journal of Medicinal Chemistry;2023-07-13

4. Enhanced metabolic activation of and platelet response to clopidogrel in T cell-deficient mice through induction of Cyp2c and Cyp3a and inhibition of Ces1;Journal of Thrombosis and Haemostasis;2023-05

5. COVID-19 and beyond: Reassessing the role of thymosin alpha1 in lung infections;International Immunopharmacology;2023-04